(Total Views: 485)
Posted On: 03/16/2020 9:15:16 AM
Post# of 153964
Re: Cytodynamite #21689
You and others are overreacting to the correction to last week’s PR. Here is what the PR said about the correction to last week:
“Patient #1 had missed one treatment of carboplatin and will continue to be treated with carboplatin and leronlimab.“
We don’t know where the mistake in communication occurred. Did the patient and/or doctor miscommunicate and was the correction given to CYDY after the PR? That’s what it appear happened to me.
The facts are clear: the the patient is improving on leronlimab and will continue with treatment in the trial. That’s all that matters.
You’re not fooling anyone by acting concerned about bashers.
“Patient #1 had missed one treatment of carboplatin and will continue to be treated with carboplatin and leronlimab.“
We don’t know where the mistake in communication occurred. Did the patient and/or doctor miscommunicate and was the correction given to CYDY after the PR? That’s what it appear happened to me.
The facts are clear: the the patient is improving on leronlimab and will continue with treatment in the trial. That’s all that matters.
You’re not fooling anyone by acting concerned about bashers.
(10)
(0)
